China’s Changle Hengshen, DSM subsidiary to build capro unit

06 August 2012 10:06  [Source: ICIS news]

SINGAPORE (ICIS)--China’s Changle Hengshen Synthetic Fabric Technology and Holland’s DSM Fibre Intermediates will start to build a 1m tonne/year caprolactam (capro) joint venture in Fujian province at the end of this year, an official from Changle Hengshen said on Monday.

The two companies have signed a non-binding letter of intent on the capro project on 16 July, and details will be discussed over the coming months, the source added.

The project will consist of Phase 1 with a 400,000 tonne/year capro unit and Phase 2 with a 600,000 tonne/year unit, according to the source.

The first phase will cost yuan (CNY) 10bn ($1.57bn), and construction is expected to start at the end of this year and be completed in 2015, according to the source.

The schedule for the second phase will depend on the operating rate of the 400,000 tonne/year capro unit after its start-up, the source said.

Details on the second phase, including financial details, have not been confirmed, according to the source.

($1 = CNY6.37)

By: Viola Pan
+65 6780 4359

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly